To evaluate the incidence of patients with a positive test for SARS-CoV-2, performed in the preoperative screening for patients treated at the institution
Cohort, prospective, observational study to evaluate the incidence of asymptomatic patients
with a positive SARS-CoV-2 test detected in the preoperative screening program of the
institution.
Diagnostic Test: PT-PCR test for SARS-CoV-2
Screening test for the diagnosis of SARS-CoV-2 in asymptomatic patients
Inclusion Criteria:
- Patients with elective surgery scheduled at the IBCC, including those diagnosed with
any type of cancer;
- Patients who will undergo the screening test for SARS-COV-2 by RT-PCR (nasal swab),
according to the guidelines and protocol of the hospital
Exclusion Criteria:
- Urgent or emergency surgery;
- Screening test for SARS-COV-2 not performed
- Incomplete data in the institutional database
Instituto Brasileiro de Controle do Cancer - IBCC
Sao Paulo, Brazil
Investigator: Alayne Yamada, PhD
Contact: +551134744242
alayne.pesquisa@ibcc-mooca.org.br
Investigator: Andre Lopes, MD
Andre Lopes, MD
+551134744242
andrelopes1002@hotmail.com
Alayne Yamada, PhD
+551134744242
alayne.pesquisa@ibcc-mooca.org.br
Andre Lopes, MD, Principal Investigator
Instituto Brasileiro de Controle do Cancer